Skip to main content Accessibility help
  • Print publication year: 2009
  • Online publication date: August 2010

Chapter 7 - Systemic therapies for gynaecological cancers

Further reading

AhmedAA, MillsAD, IbrahimAE, TempleJ, BlenkironC, ViasM, et al. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 2007; 12: 514–27.
BristowRE, EisenhauerEL, SantillanA, ChiDS. Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol 2007; 104: 480–90.
IngelfingerFJ.Arrogance. N Engl J Med 1980; 303: 1507–11.
LiuB, EarlHM, PooleCJ, DunnJ, Kerr, DJ. Etoposide protein binding in cancer patients. Cancer Chemother Pharmacol 1995; 36: 506–12.